Latest Threads

BHM Capital Financial Services P.S.C., a private joint stock company regulated by SCA, held a meeting on 11th March 2024. The meeting, chaired by Mr. Alhur Mohammed Al Suwaidi, took place online and lasted from 11:00 AM to 12:00 PM. The quorum of total attendance was 69.075%, distributed as 1.23% personal attendance, 67.85% proxy, and 69.075% electronic voting. The assembly approved the Board of Directors' report, the Auditor's report, and the Consolidated Financial Statements, all for the financial year ended 31/12/2023.

BHM Capital, a prominent financial institution in the UAE, recently concluded its participation in Al Ain University's Career Development and Training Fair. This participation was part of a memorandum of understanding signed between the two entities in October 2021, which included the creation of a virtual trading room at the university to train students on investment operations and stock market. The CEO of BHM Capital, Abdel Hadi Al Sa’di, expressed his delight at the enthusiasm shown by students towards the financial sector. The BHM Capital platform at the exhibition attracted a significant number of students and graduates interested in learning about the company's work and gaining practical experience in investment and trading procedures.

The GFH Financial Group B.S.C. has announced that it will begin repurchasing its shares (treasury shares) from March 12, 2024. This decision is in line with the resolution made during the Ordinary General Meeting on October 14, 2021, which approved the repurchase of up to 10% of the group's total issued shares. The company has obtained approval from the Central Bank of Bahrain (CBB) for this action. The announcement was signed by Mariam Jowhary, the Head of Compliance & AML.

Resolution No. 322 of 2024 announces the temporary suspension of trading for the shares of Gulf Pharmaceutical Industries. This suspension is in accordance with Article No. 16 of the Regulations Concerning the Listing of Securities on ADX. The suspension is due to a Board of Directors Meeting for Gulf Pharmaceutical Industries, which coincides with the trading session at ADX. Trading of the company's shares will be suspended from 09:00 on 14-Mar-2024 until ADX receives the meeting results. The resolution instructs all departments in ADX to execute this resolution and it will be circulated to SCA, the concerned company, all departments at ADX, and all brokers accredited by ADX. The resolution was issued on 11/03/2024.